8 results were returned
We were successful in defending our clients in a major Supplementary Protection Certificate (SPC) case.
We have advised Aphria Deutschland GmbH on its tender for the cultivation, processing and delivery of cannabis for medical purposes.
If a patentee undertakes actions with respect to a patent of the same patent family (e.g. waiving the parent patent of a divisional patent), this is often negatively characterised as playing the “Divisional Game”. We ...
Sanofi sought a compulsory licence for the distribution of its high cholesterol drug Praluent® but this was dismissed in preliminary proceedings (docket no: 3 LiQ 1/18).
On September 26, 2019, the Higher Regional Court of Düsseldorf confirmed on appeal that Teva Pharmaceutical Industries Ltd. (“Teva”) – one of Bird & Bird’s key clients – is entitled to a preliminary injunction against ...
Since liberalisation at the beginning of 2017, industrial and medical Cannabis have experienced a boom in Germany.
Today the German Constitutional Court (Bundesverfassungsgericht) ruled that the German ratification act for the Unified Patent Court Agreement (UPCA) is void, because an insufficient number of members of parliament was ...
In the wake of the COVID-19 pandemic the German government has recently passed a “corona crisis package”. The so-called Act for protecting the Population in the Event of an Epidemic Situation of National Importance, the ...